Chitose Internasional Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Chitose Internasional Tbk. trades at Rp173 (market cap 176B, 169.4K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 2.7× Chitose Internasional Tbk.'s market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 169.4K). Which is the better fit depends on your goals.
| CINT | PRDL | |
|---|---|---|
Market Cap | 176B | 470.58B |
Volume | 169.4K | 28.43M |
Lot | 1.69K | 284.34K |
Turnover | 29.86M | 7.8B |
Average Price | 176.25 | 274.19 |
Value | 29.86M | 7.8B |
Indicative Equilibrium Price | — | 270 |
Indicative Equilibrium Volume | — | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Chitose Internasional Tbk (the Company) formerly PT Chitose Indonesia Manufacturing was established based on Notarial Deed No. 21 dated June 15, 1978 of Widyanto Pranamihardja, S.H., notary in Bandung. The name was changed to PT Chitose Internasional on October 4, 2013. The company with brand Chitose has a high market share in all product categories, including folding chair, hotel, restaurant, food coourt, office and working chair and chair school.
Read more on CINT →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →